UroToday4h
ASCO GU 2025: Does Treatment for Mental Health Illness Impact Prostate Cancer Treatment and Outcomes?
Annual Symposium held in San Francisco, CA between February 13–15, 2025 was host to prostate cancer poster session. Dr. Zachary Klaassen presented the results of a population-based analysis evaluating ...
Get screened for the leading cancer type in men at this Fort Worth event
Prostate cancer is the leading cancer type in men. Getting screened can help you catch cancer early, when it’s easier to ...
Pfizer reports positive results for Talzenna/Xtandi combo
Pfizer (PFE) reported positive results from a Phase 3 study of Talzenna in combination with Xtandi in the treatment of ...
Pfizer reports survival benefit in prostate cancer study
NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $17.4 billion, has announced results from its Phase 3 TALAPRO-2 study which show that a combination of ...
Targeted Oncology2d
FDA Grants 510(k) Clearance to Ibex Prostate Detect AI for Prostate Cancer
The FDA has granted a 510 (k) clearance to the Ibex Prostate Detect software (formerly Galen Second Read). The Ibex Prostate ...
New treatment for hair loss shows promise — paid volunteers needed to test it out
I can tell you that VDPHL01 has a unique profile unlike current FDA-approved treatments, which are associated with cardiac ...